U of L Research Foundation Inc. Board of Directors Meeting
November 25, 2002, In Open Session
The University of Louisville Research Foundation Inc. Board of Directors met on Monday, November 25, 2002, in the Jefferson Room, Grawemeyer Hall, with members present and absent as follows:
Mr. Kevin D. Cogan, Chair
Mr. Ulysses L. Bridgeman, Jr.
Ms. Virginia C. Brown
Mr. Tommie Burns, Jr.
Ms. Linda Wallbaum Cauble
Prof. David Ensign
Mr. Nathaniel E. Green
Ms. Joyce Hagen
Mr. Grant Helman
Ms. Jessica S. Loving
Mr. Christopher J. Marlin
Mr. J. Chester Porter
Mr. Mike Livingston
Mr. William Mulloy, Sr.
Ms. Sandra Metts Snowden
Ms. Elizabeth Worland
Ms. Marie K. Abrams
Mr. Owsley B. Frazier
Ms. Mary A. Yarmuth
From the University:
Dr. James Ramsey, President
Dr. Shirley Willihnganz, Acting Provost
Ms. Angela D. Koshewa, University Counsel
Mr. Joseph S. Beyel, Vice President for Development and
Mr. Daniel Hall, Vice President for University Relations
Dr. Nancy Martin, Vice President for Research
Mr. Ronald Moore, Vice President for Information & Technology
Mr. Larry Owsley, Vice President for Finance & Administration
Dr. Eugene Gilchrist, Vice President for New Ventures
Dr. Dee Maynard, CEO, Minerva Ventures
Dr. Larry Cook, President, UofL Medical School Fund, Inc.
Mr. Michael Curtin, Director, Planning and Budget
Ms. Terri Rutledge, Asst. VP for Administration
Ms. Mordean Taylor-Archer, Office of the Provost
Dr. Blaine Hudson, Chair, Pan-African Studies
Ms. Carolyn Cochran, Assistant to the Provost
Ms. Rae Goldsmith, Associate VP for Communications & Marketing
Mr. Kevin Miller, Associate Athletics Director
Ms. Kathleen Smith, Assistant Secretary
Ms. Trisha Wolf, Board Liaison
Ms. Debbie Dougherty, Board Liaison
I. Call to Order
Having determined a quorum present, Chair Cogan called the meeting to order at 1:10 p.m.
II. Action Item: Approval of Minutes of meeting, 6/24/02
Ms. Snowden made a motion, which Ms. Hagen seconded, to approve the minutes of June 24, 2002. The motion passed.
III. Action Item: Approval of Recommendation Regarding Security Clearance and Managerial Group
Chair Cogan reviewed the recommendation to the Board concerning the security clearance and managerial group. He noted this resolution updates the managerial group of the University of Louisville Research Foundation with full authority and responsibility for administering contracts involving access to classified material. The Chair stated that to carry out the purposes of this delegation and to meet federal regulations, the Board must take formal action to waive access to classified information for all directors not designated in the managerial group and must waive access to classified information for each new director. Ms. Snowden made a motion, which Ms. Worland seconded, to approve the
President’s recommendation that the Board of Directors adopt the attached Resolution revising the Managerial Group of the Board of Directors of the University of Louisville Research Foundation, Inc. and waiving of security clearance for directors not a part of the managerial group, and that the President be authorized to take any other steps necessary with regard to agreements or assurances to the Defense Investigative Service to effect the facility security clearance of the University of Louisville Research Foundation, Inc. and clearance of its personnel including compliance with the provisions of the Industrial Security Manual or other Federal government policy relating to safeguarding of classified information.
IV. Information Item: Minerva Ventures Quarterly Report
V. Information Item: Interim Financial Statements for U of L Research Foundation Inc.
Vice President Gilchrist reviewed the accomplishments as noted in the quarterly report for period ending September 30, 2002 (copy attached). Dr. Gilchrist stated that out of the universities visited with similar ventures, Minerva Ventures was the first to turn a profit back to its shareholders. He recognized the exceptional work of CEO Dee Maynard. Dr. Maynard reported on the status of the three investments, Aptamera, Inc., Medeqco Medical Technologies, LLC, and Minerva Books. She noted that since generation of the September 30 report, Minerva Ventures had invested in another entity, Indigo Olive. She further noted that Minerva Ventures projected its goal to return the seed money approved by the Board of Trustees in 3-5 years. Chair Cogan thanked Vice President Gilchrist and Dr. Maynard for their informative presentations.
VI. Other Business
Report of the President
President Ramsey shared a recent Business First article chronicling the new venture emerging from Dr. Don Miller's research team. Dr. Ramsey shared his enthusiasm about the medical innovation of U of L's cancer team, the cellular theraputics group, and the tremendous potential from the creation of U of L's Cardiac Innovations Institute and cardiology programs. He expressed his appreciation to the Board for its confidence as U of L develops this new dimension of its research enterprise, noting commercialization was a "Bucks for Brains" initiative.
Ms. Loving made a motion, which Ms. Snowden seconded, to adjourn the meeting at 1:16 p.m. The motion passed.